208 related articles for article (PubMed ID: 34854585)
1. [Irreversible electroporation: local tumor ablation with systemic immune effect].
Geboers B; Timmer FEF; van den Tol PM; de Gruijl TD; Scheffer HJ; Meijerink MR
Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854585
[TBL] [Abstract][Full Text] [Related]
2. [Irreversible electroporation: a new form of image-guided tumour ablation].
Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
[TBL] [Abstract][Full Text] [Related]
3. Irreversible Electroporation in Hepatopancreaticobiliary Tumours.
Ruarus AH; Vroomen LGPH; Puijk RS; Scheffer HJ; Zonderhuis BM; Kazemier G; van den Tol MP; Berger FH; Meijerink MR
Can Assoc Radiol J; 2018 Feb; 69(1):38-50. PubMed ID: 29458954
[TBL] [Abstract][Full Text] [Related]
4. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation for Colorectal Liver Metastases.
Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
[TBL] [Abstract][Full Text] [Related]
6. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
Front Immunol; 2021; 12():811726. PubMed ID: 35069599
[TBL] [Abstract][Full Text] [Related]
7. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
8. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
[TBL] [Abstract][Full Text] [Related]
9. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation: Beyond the limits of tumor ablation.
Alonso-González R; Abadal Villayandre JM; Gálvez Gonzalez E; Álvarez Perez MJ; Méndez Alonso S; de Gregorio Ariza MA
Radiologia (Engl Ed); 2024; 66(1):47-56. PubMed ID: 38365354
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
[TBL] [Abstract][Full Text] [Related]
12. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
[TBL] [Abstract][Full Text] [Related]
13. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
Simmerman E; Chung J; Lawson A; Kruse E
J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
[TBL] [Abstract][Full Text] [Related]
14. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
[TBL] [Abstract][Full Text] [Related]
15. [Irreversible electroporation: local, non-thermal, ablation therapy of malignant tumours].
Janík V; Skrabalová D; Gürlich R; Málek J
Cas Lek Cesk; 2013; 152(2):67-75. PubMed ID: 23641678
[TBL] [Abstract][Full Text] [Related]
16. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Hepatic Lesions After non-Thermal Tumor Ablation by Irreversible Electroporation in a Pig Model.
Jeon SM; Davaa E; Jiang Y; Jenjob R; Truong NT; Shin KJ; Jeong S; Yang SG
Technol Cancer Res Treat; 2023; 22():15330338221147122. PubMed ID: 37861099
[TBL] [Abstract][Full Text] [Related]
18. Local ablation of pancreatic tumors: State of the art and future perspectives.
Granata V; Grassi R; Fusco R; Belli A; Palaia R; Carrafiello G; Miele V; Grassi R; Petrillo A; Izzo F
World J Gastroenterol; 2021 Jun; 27(23):3413-3428. PubMed ID: 34163121
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation for liver cancer ablation: A meta analysis.
Yu M; Li S
Eur J Surg Oncol; 2022 Jun; 48(6):1321-1330. PubMed ID: 35012834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
